BILIBILI-W (09626) has completed the issuance of $500 million of convertible preferred notes and concurrently repurchased approximately $100 million of Class Z common stock.
Bilibili-W (09626) announced that it has completed the offering of its previously disclosed $500 million principal amount of convertible preferred notes maturing in 2031, along with the simultaneous repurchase of approximately $100 million of Class Z common stock. The company has also been informed by relevant financial institutions that it will assist several note investors in hedging through the simultaneous placement of borrowed Class Z common stock, which, together with the secondary placement of Class Z common stock conducted by a subsidiary of Tencent Holdings Limited (collectively referred to as "Tencent"), has been completed today. The additional $200 million principal amount of notes subscribed by Tencent and the companys repurchase of approximately $200 million of shares from Tencent will become effective only upon approval by independent shareholders at the company's special shareholder meeting and the fulfillment of other customary closing conditions.
BILIBILI-W (09626) announced the completion of the sale of its previously announced $500 million principal amount of convertible preferred notes due in 2031, along with a simultaneous buyback of approximately $100 million of Class Z common stock. The company has also been informed by relevant financial institutions that, to assist several note investors with hedging, it has conducted a simultaneous placement of borrowed Class Z common stock, along with a secondary placement of Class Z common stock by a subsidiary of TENCENT Limited (collectively referred to as Tencent), both of which have been completed today. The settlement of Tencent's additional subscription for $200 million in principal amount of notes and the company's buyback of approximately $200 million of shares from Tencent is still subject to approval by independent shareholders at the company's special general meeting and the fulfillment of other customary closing conditions.
Related Articles

MEGA GENOMICS (06667) repurchased 85,000 shares for HKD 615,600 on September 9.

On September 9, KUAISHOU-W (01024) spent HK$19.9872 million to repurchase 618,000 shares.

Guangzhou LBP Medicine Science & Technology (688393.SH) shareholder Zhuji Gaotiejia and its concerted parties plan to reduce their holdings by no more than 1%.
MEGA GENOMICS (06667) repurchased 85,000 shares for HKD 615,600 on September 9.

On September 9, KUAISHOU-W (01024) spent HK$19.9872 million to repurchase 618,000 shares.

Guangzhou LBP Medicine Science & Technology (688393.SH) shareholder Zhuji Gaotiejia and its concerted parties plan to reduce their holdings by no more than 1%.

RECOMMEND





